When Grammy-nominated singer-songwriter Aloe Blacc got COVID despite being vaccinated and boosted, he tried to fund research for a better solution. What he quickly found out? You can’t just write a check in biotech. Regulators require a commercialization plan, and philanthropy doesn’t move science through clinical trials or get you a license on university IP. Now, he’s bootstrapping a cancer drug platform targeting pancreatic cancer, a disease that […]
Technology
·
Aloe Blacc’s fame means nothing in biotech (and that’s the point)
CN
CitrixNews Staff
Originally reported by TechCrunch. Read the full story at the original source.
Related Articles
Technology
Cursor makes its biggest India push yet ahead of SpaceX acquisition with localized pricing
Weeks before its expected acquisition by SpaceX closes, AI coding startup Cursor is making its biggest push into India y...
CitrixNews Staff
·
1 hour ago
Technology
Anthropic’s Dario Amodei responds: doesn’t oppose open-weight models, but fears Chinese AI
Anthropic founder and CEO Dario Amodei responded on Monday afternoon to murmuring in the industry that his company someh...
CitrixNews Staff
·
5 hours ago
Technology
France Records Its First-Ever Pyrocumulonimbus Cloud Amid Record-Smashing Fires
CommentLoaderSave StorySave this storyCommentLoaderSave StorySave this storyFirefighters in France are confronting a phe...
CitrixNews Staff
·
6 hours ago
Technology
X Money begins limited US rollout
Only Premium and Premium X subscribers get the privilege of banking with Elon for now.
CitrixNews Staff
·
7 hours ago